MS MBA - LakeShore Biopharma CFO Director
| LSBCF Stock | 0.85 0.00 0.00% |
Director
MS MBA is CFO Director of LakeShore Biopharma Co
| Age | 51 |
| Phone | 86 10 8920 2086 |
| Web | https://www.lakeshorebio.com |
LakeShore Biopharma Leadership Team
Elected by the shareholders, the LakeShore Biopharma's board of directors comprises two types of representatives: LakeShore Biopharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LakeShore. The board's role is to monitor LakeShore Biopharma's management team and ensure that shareholders' interests are well served. LakeShore Biopharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LakeShore Biopharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Honggang Teng, Head Management | ||
| CFA MBA, Chief President | ||
| Yuan Liu, Head Research | ||
| MS MBA, CFO Director | ||
| Zhiyuan Ran, Head Sales | ||
| Wang Xu, CEO Director |
LakeShore Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is LakeShore Biopharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Revenue | 614.96 M | ||||
| EBITDA | (48.54 M) | ||||
| Net Income | (99.98 M) | ||||
| Total Debt | 414.4 M | ||||
| Cash Flow From Operations | (120.98 M) | ||||
| Number Of Employees | 758 | ||||
| Total Asset | 1.37 B | ||||
| Retained Earnings | (2.41 B) | ||||
| Working Capital | 17.47 M | ||||
| Net Asset | 1.37 B |
Currently Active Assets on Macroaxis
When determining whether LakeShore Biopharma is a strong investment it is important to analyze LakeShore Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LakeShore Biopharma's future performance. For an informed investment choice regarding LakeShore Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LakeShore Biopharma Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LakeShore Biopharma. If investors know LakeShore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LakeShore Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of LakeShore Biopharma is measured differently than its book value, which is the value of LakeShore that is recorded on the company's balance sheet. Investors also form their own opinion of LakeShore Biopharma's value that differs from its market value or its book value, called intrinsic value, which is LakeShore Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LakeShore Biopharma's market value can be influenced by many factors that don't directly affect LakeShore Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LakeShore Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if LakeShore Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LakeShore Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.